-
1دورية أكاديمية
المؤلفون: Ricardos Ghanem, Sylvie Glaisner, Arthur Bobin, Anne-Marie Ronchetti, Sophie Cereja, Bertrand Joly, Célia Salanoubat, Guillemette Fouquet
المصدر: Leukemia Research Reports, Vol 21, Iss , Pp 100407- (2024)
مصطلحات موضوعية: Myeloma, Neurotoxicity, Cerebrovascular complication, Posterior reversible encephalopathy syndrome, Chemotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
العلاقة: http://www.sciencedirect.com/science/article/pii/S221304892300047XTest; https://doaj.org/toc/2213-0489Test
-
2دورية أكاديمية
المؤلفون: Luis Veloza, Doriane Cavalieri, Edoardo Missiaglia, Albane Ledoux-Pilon, Bettina Bisig, Bruno Pereira, Christophe Bonnet, Elsa Poullot, Leticia Quintanilla-Martinez, Romain Dubois, Francisco Llamas-Gutierrez, Céline Bossard, Roland De Wind, Fanny Drieux, Juliette Fontaine, Marie Parrens, Jeremy Sandrini, Virginie Fataccioli, Marie-Hélène Delfau-Larue, Adrien Daniel, Faustine Lhomme, Lauriane Clément-Filliatre, François Lemonnier, Anne Cairoli, Pierre Morel, Sylvie Glaisner, Bertrand Joly, Abderrazak El Yamani, Kamel Laribi, Emmanuel Bachy, Reiner Siebert, David Vallois, Philippe Gaulard, Olivier Tournilhac, Laurence de Leval
المصدر: Haematologica, Vol 108, Iss 1 (2022)
مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
العلاقة: https://haematologica.org/article/view/10680Test; https://doaj.org/toc/0390-6078Test; https://doaj.org/toc/1592-8721Test
-
3
المؤلفون: Murielle Roussel, Valérie Lauwers-Cances, Margaret Macro, Xavier Leleu, Bruno Royer, Cyrille Hulin, Lionel Karlin, Aurore Perrot, Cyrille Touzeau, Marie-Lorraine Chrétien, Sophie Rigaudeau, Mamoun Dib, Emmanuelle Nicolas-Virelizier, Martine Escoffre-Barbe, Karim Belhadj, Clara Mariette, Anne-Marie Stoppa, Carla Araujo, Chantal Doyen, Jean Fontan, Brigitte Kolb, Laurent Garderet, Sabine Brechignac, Jean-Valère Malfuson, Arnaud Jaccard, Pascal Lenain, Cécile Borel, Benjamin Hebraud, Omar Benbrahim, Véronique Dorvaux, Salomon Manier, Karine Augeul-Meunier, Marie-Christiane Vekemans, Edouard Randriamalala, Driss Chaoui, Jo Caers, Carine Chaleteix, Lofti Benboubker, Laure Vincent, Sylvie Glaisner, Patricia Zunic, Borhane Slama, Jean-Richard Eveillard, Catherine Humbrecht-Kraut, Véronique Morel, Philippe Mineur, Jean-Claude Eisenmann, Hélène Demarquette, Valentine Richez, Marguerite Vignon, Denis Caillot, Thierry Facon, Philippe Moreau, Anne-Laurène Colin, Pascale Olivier, Soraya Wuilleme, Hervé Avet-Loiseau, Jill Corre, Michel Attal
المساهمون: UCL - (MGD) Service d'hématologie, UCL - SSS/IREC/MONT - Pôle Mont Godinne
المصدر: Blood, Vol. 139, no. 18, p. 2747-2757 (2022)
مصطلحات موضوعية: Bortezomib, Antineoplastic Combined Chemotherapy Protocols, Immunology, Humans, Cell Biology, Hematology, Multiple Myeloma, Melphalan, Transplantation, Autologous, Biochemistry
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca2eb889eef161542d4f0290176e12eeTest
https://doi.org/10.1182/blood.2021014635Test -
4
المؤلفون: V. de Wilde, O. Tournilhac, Frédéric Lhomme, Bruno Villemagne, L. Clément-Filliatre, Bettina Bisig, P. Gaulard, E. Missiglia, Fanny Drieux, Elsa Poullot, Luc Xerri, A. El Yamani, K. Queru, A. Daniel, Serge Bologna, Ghandi Damaj, Albane Ledoux-Pilon, Christophe Bonnet, Anne Cairoli, E. Tchernonog, E. Dupont, R. Noël, Marie-Christine Copin, David Sibon, Céline Bossard, L. de Leval, F. Llamas Gutierrez, E. Fleck, Marie Parrens, David Vallois, T. Brotelle, V. Letailleur, R. De Wind, F. Lemmonier, Sylvie Glaisner, D. Cavalieri, Virginie Fataccioli, Pierre Morel, H. Monjanel
المصدر: Hematological Oncology. 39
مصطلحات موضوعية: Cancer Research, Pathology, medicine.medical_specialty, Oncology, Intestinal T-cell lymphoma, business.industry, Cohort, Medicine, Clinico pathological, Hematology, General Medicine, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0e03012884f33bfa6a7cc7139732acfaTest
https://doi.org/10.1002/hon.44_2879Test -
5
المؤلفون: Frédérique Kuhnowski, Jean Philippe Richardet, Marie-Pierre Moles, Sébastien Mulé, Sylvie Glaisner, Manel Bedoui, Jehane Fadlallah, Julien Calderaro, Luc-Matthieu Fornecker, Pierre-Edouard Debureaux, Daniel Azoulay, Delphine Le Febvre de Nailly, Jerome Tamburini, Jehan Dupuis, Emmanuelle Tavernier, Corinne Haioun, David Sibon, Vincent Camus
المصدر: Bone Marrow Transplantation. 55:1834-1836
مصطلحات موضوعية: Transplantation, medicine.medical_specialty, business.industry, Hematopoietic Stem Cell Transplantation, Hepatic Veno-Occlusive Disease, Hematology, Transplantation, Autologous, Oxaliplatin, Surgery, Autologous stem-cell transplantation, medicine, Humans, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f0b50c3062968576fd0fe0a66149389Test
https://doi.org/10.1038/s41409-020-0796-6Test -
6
المؤلفون: Andrew Lister, Maria Gomes da Silva, John F. Seymour, Harald Zeuner, Jonathan Farhi, John Catalano, Véronique Dorvaux, Sirpa Leppä, David Simpson, Loic Ysebaert, Steven Le Gouill, David Belada, Anne Sonet, Emmanuel Bachy, Pauline Brice, Luc Xerri, Tanin Intragumtornchai, Lars Møller Pedersen, Anne Vekhoff, Sylvie Glaisner, Jane Estell, Gilles Salles, Alejandro Martín, Hervé Tilly, Olivier Casasnovas, François Lemonnier, Fritz Offner, Jean Gabarre, Armando López-Guillermo, Gustavo Milone, Pierre Feugier
المساهمون: Department of Oncology, HUS Comprehensive Cancer Center, University of Helsinki
المصدر: Journal of Clinical Oncology
مصطلحات موضوعية: Oncology, Male, Cancer Research, Time Factors, Follicular lymphoma, THERAPY, 0302 clinical medicine, Antineoplastic Agents, Immunological, Prednisone, CYCLOPHOSPHAMIDE, Lymphoma and Myeloma, Lymphoma, Follicular, R-CVP, Aged, 80 and over, Middle Aged, CHEMOTHERAPY, Progression-Free Survival, 3. Good health, 030220 oncology & carcinogenesis, Disease Progression, Rituximab, Female, TRIAL, medicine.drug, Adult, PREDNISONE, medicine.medical_specialty, Vincristine, Cyclophosphamide, 3122 Cancers, 03 medical and health sciences, Young Adult, Internal medicine, RAPID COMMUNICATIONS, medicine, Humans, Progression-free survival, NON-HODGKINS-LYMPHOMA, VINCRISTINE, Watchful Waiting, Aged, business.industry, medicine.disease, PHASE-III, Lymphoma, Clinical trial, business, RESPONSE DURATION, 030215 immunology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa471ffbe353d233f079b3d515d2f2afTest
http://europepmc.org/articles/PMC6823890Test -
7
المؤلفون: Véronique Dorvaux, Marc Delord, Marc Muller, Melanie Mercier, Hacene Zerazhi, Jacques Chapiro, Eric Jourdan, Laurence Legros, Françoise Rigal-Huguet, Iona Vaida, François Guilhot, Alberto Santagostino, Claude Preudhomme, Joelle Guilhot, Valérie Coiteux, Jean-Michel Miclea, Jean-Jacques Kiladjian, Emmanuel Gyan, Aude Charbonnier, Amélie Penot, Eric Deconinck, Franck E. Nicolini, Gabriel Etienne, Hyacinthe Johnson-Ansah, Jean-Claude Chomel, Kamel Ghomari, Nathalie Cambier, Delphine Lebon, Viviane Dubruille, Sylvie Glaisner, Philippe Rousselot, Loïc Fouillard, Alain Delmer, Bertrand Joly, Pascal Lenain, Claude-Eric Bulabois, Martine Escoffre Barbe, Christian Berthou, Isabelle Plantier, Delphine Rea, Marc G. Berger, Magda Alexis, Francois-Xavier Mahon, Pascale Cony-Makhoul, Ludovic Lhermitte, Lydia Roy, Jean-Michel Cayuela, Denis Caillot, Anne Vekhoff, Martine Gardembas, Bertrand Pollet, Agnès-Paule Guerci-Bresler, Yazid Arkam, Hervé Maisonneuve, Frédéric Maloisel
المساهمون: Role of intra-Clonal Heterogeneity and Leukemic environment in ThErapy Resistance of chronic leukemias (CHELTER), Université Clermont Auvergne (UCA)
المصدر: Leukemia
Leukemia, Nature Publishing Group: Open Access Hybrid Model Option B, 2021, ⟨10.1038/s41375-020-01117-w⟩
Leukemia, Springer Nature, 2021, ⟨10.1038/s41375-020-01117-w⟩مصطلحات موضوعية: 0301 basic medicine, Cancer Research, medicine.medical_specialty, [SDV]Life Sciences [q-bio], Chronic myeloid leukaemia, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Interferon, Internal medicine, Medicine, Adverse effect, ComputingMilieux_MISCELLANEOUS, business.industry, Imatinib, [SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology, Hematology, 3. Good health, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Major Molecular Response, Pegylated interferon alpha 2a, Toxicity, Cytarabine, business, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e82d474ec7e8650bf9829473b30a0c5Test
https://hal.uca.fr/hal-03122967Test -
8
المؤلفون: Hervé Tilly, Thierry Fest, Loic Ysebaert, Sylvie Glaisner, Guillaume Cartron, Rene-Olivier Casasnovas, Steven Le Gouill, Jean-Claude Eisenmann, Roch Houot, Marie-Hélène Delfau-Larue, Marie-Laure Boulland, Gilles Salles, Gian Matteo Pica, Franck Morschhauser, Asma Beldi-Ferchiou, François Lemonnier, Pierre Feugier, Luc Xerri, Pascal Godmer, Vincent Ribrag, Hervé Maisonneuve
المساهمون: Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), CHU Pontchaillou [Rennes], Service d'Hématologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon (CHD Vendée), CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), CHU Henri Mondor, Centre Hospitalier Métropole Savoie [Chambéry], Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), Génomique et Médecine Personnalisée du Cancer et des Maladies Neuropsychiatriques (GPMCND), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Emile Muller [Mulhouse] (CH E.Muller Mulhouse), Groupe Hospitalier de Territoire Haute Alsace (GHTHA), Regulation of Bcl2 and p53 Networks in Multiple Myeloma and Mantle Cell Lymphoma (CRCINA-ÉQUIPE 10), Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Université d'Angers (UA)-Université de Nantes (UN)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Centre hospitalier universitaire de Nantes (CHU Nantes), Institut Gustave Roussy (IGR), Département d'hématologie [Gustave Roussy], Centre hospitalier Bretagne Atlantique (Morbihan) (CHBA), CRLCC René Huguenin, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), Recherche translationelle relations hôte-pathogènes, Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE), Université de Nantes (UN)-Université de Nantes (UN)-Centre hospitalier universitaire de Nantes (CHU Nantes)-Centre National de la Recherche Scientifique (CNRS)-Université d'Angers (UA), CHU Montpellier, Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM), Bernardo, Elizabeth, CHU Henri Mondor [Créteil], Université de Toulouse (UT)-Université de Toulouse (UT)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Institut National de la Santé et de la Recherche Médicale (INSERM)
المصدر: Blood Advances
Blood Advances, 2020, 4 (14), pp.3217-3223. ⟨10.1182/bloodadvances.2020001955⟩
Blood Adv
Blood Advances, The American Society of Hematology, 2020, 4 (14), pp.3217-3223. ⟨10.1182/bloodadvances.2020001955⟩مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, Follicular lymphoma, [SDV.CAN]Life Sciences [q-bio]/Cancer, 03 medical and health sciences, 0302 clinical medicine, [SDV.CAN] Life Sciences [q-bio]/Cancer, Internal medicine, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lenalidomide, Lymphoma, Follicular, 030304 developmental biology, 0303 health sciences, Chemotherapy, Lymphoid Neoplasia, business.industry, Hematology, medicine.disease, Prognosis, Minimal residual disease, 3. Good health, Lymphoma, Regimen, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Rituximab, Bone marrow, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdd46e191f95afc9eeae6e8aa9f49e79Test
https://www.hal.inserm.fr/inserm-03498367/documentTest -
9
المؤلفون: Michel Attal, Frédérique Orsini-Piocelle, Herve Avet Loiseau, Lotfi Benboubker, Carla Araujo, Mourad Tiab, Sabine Brechignac, Eric Voog, Laurent Garderet, Karim Belhadj, Margaret Macro, Jean-Richard Eveillard, Brigitte Pegourie, Gerald Marit, Carine Chaleteix, Claire Mathiot, Arnaud Jaccard, Pascal Lenain, Benoit Berge, Bruno Royer, Anne-Marie Stoppa, Aurore Perrot, Mohamad Mohty, Xavier Leleu, Frédérique Kuhnowski, Murielle Roussel, Cyrille Hulin, Sylvie Glaisner, Ingrid Lafon, Martine Escoffre-Barbe, Olivier Allangba, Lionel Karlin, Marc Wetterwald, Philippe Moreau, Thierry Facon, Jean Claude Eisenmann, Eric Jourdan
المصدر: Blood. 138:2753-2753
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, Phases of clinical research, Cell Biology, Hematology, Pomalidomide, medicine.disease, Biochemistry, First relapse, Maintenance therapy, Internal medicine, medicine, Stem cell, business, Multiple myeloma, Dexamethasone, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::72e44a8e41b4709f7f66a7fdb6ab9020Test
https://doi.org/10.1182/blood-2021-152136Test -
10
المؤلفون: Francois, Guilhot, Françoise, Rigal-Huguet, Joëlle, Guilhot, Agnès-Paule, Guerci-Bresler, Frédéric, Maloisel, Delphine, Rea, Valérie, Coiteux, Martine, Gardembas, Christian, Berthou, Anne, Vekhoff, Eric, Jourdan, Marc, Berger, Loïc, Fouillard, Magda, Alexis, Laurence, Legros, Philippe, Rousselot, Alain, Delmer, Pascal, Lenain, Martine, Escoffre Barbe, Emmanuel, Gyan, Claude-Eric, Bulabois, Viviane, Dubruille, Bertrand, Joly, Bertrand, Pollet, Pascale, Cony-Makhoul, Hyacinthe, Johnson-Ansah, Melanie, Mercier, Denis, Caillot, Aude, Charbonnier, Jean-Jacques, Kiladjian, Jacques, Chapiro, Amélie, Penot, Véronique, Dorvaux, Iona, Vaida, Alberto, Santagostino, Lydia, Roy, Hacene, Zerazhi, Eric, Deconinck, Herve, Maisonneuve, Isabelle, Plantier, Delphine, Lebon, Yazid, Arkam, Nathalie, Cambier, Kamel, Ghomari, Jean-Michel, Miclea, Sylvie, Glaisner, Jean-Michel, Cayuela, Jean-Claude, Chomel, Marc, Muller, Ludovic, Lhermitte, Marc, Delord, Claude, Preudhomme, Gabriel, Etienne, François-Xavier, Mahon, Franck-Emmanuel, Nicolini
المصدر: Leukemia. 35(8)
مصطلحات موضوعية: Adult, Aged, 80 and over, Male, Dose-Response Relationship, Drug, Cytarabine, Interferon-alpha, Middle Aged, Prognosis, Recombinant Proteins, Polyethylene Glycols, Survival Rate, Young Adult, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Antineoplastic Combined Chemotherapy Protocols, Imatinib Mesylate, Humans, Female, Prospective Studies, Aged, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::5fc8a6e6e69b503d2820214392aae2a6Test
https://pubmed.ncbi.nlm.nih.gov/33483613Test